+86(1812)4514114 info@phcoker.com

Raw Tesamorelin powder (218949-48-5)

Raw Tesamorelin powder is a stabilized synthetic peptide analogue of the hypothalamic peptide, Growth Hormone Releasing………


Status: In Mass Production
Synthesized and Customized Available
Capacity: 1277kg/month

Description

Raw Tesamorelin powder (218949-48-5) video

 

Raw Tesamorelin powder (218949-48-5) Description

Raw Tesamorelin powder is a stabilized synthetic peptide analogue of the hypothalamic peptide, Growth Hormone Releasing Hormone (GHRH) indicated for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Lipodystrophy is a metabolic condition characterized by insulin resistance, fat redistribution, and hyperlipidemia associated with antiretroviral therapy for HIV infection.

Raw Tesamorelin powder is used to reduce excess fat around the stomach that is caused by taking certain HIV medications. This condition is also called lipodystrophy (LYE-poe-DIS-troe-fee).

Raw Tesamorelin powder (218949-48-5) Specifications

Product Name Raw Tesamorelin powder
Chemical Name UNII-LGW5H38VE3; LGW5H38VE3; TH9507; Egrifta; Egrifta (TN)
Brand Name Egrifta
Drug Class Peptide
CAS Number 218949-48-5/804475-66-9
InChIKey LAJJBLZKAIOLRM-YHAVXTEWSA-N
Molecular Formula C221H366N72O67S
Molecular Weight 5135.856 g/mol
Monoisotopic Mass 5135.86
Melting Point  N/A
Freezing Point N/A
Biological Half-Life 26 and 38 minutes in healthy subjects and HIV-infected patients, respectively.
Color White lyophilized powder
Solubility  Soluble in water and very slightly soluble in methanol.
Storage Temperature  -20°C Freezer
Application It can reduce excess fat (lipodystrophy) in the abdomen or stomach of HIV patients.

 


=